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ABSTRACT
Introduction : Hepatitis B virus (HBV) infection is a major cause of morbidity and mortality in the
world. Over 2 billion people are infected with HBV and 378 million are carriers. The mortality rate is
approximately 1-2 million and over 4 millions acute clinical cases are documented each year. The
prevalence of HBV infection in Indonesia is 3-20%. Vertical and horizontal transmission in newborn
and children occurs in 25-45%. Near 25-50% of children are infected before 5 years. The most
effective approach to reduce the burden of HBV infection is mass vaccination of newborns and
children.
Objectives: To determine immune response against HBV after HBV vaccine among low birth weight
(LBW) and preterm newborns after HBV vaccination, and factors related to the immune response i.e.
gender and weight gain in the first 6 months of life.
Methods: During May-July 2012, 106 infants aged 13-15 months were recruited after HBV vaccination.
They were completed 4 doses of HBV basic vaccination in 0, 2, 3, and 4 months of life. Sera were
examined for anti-HBs antibody titers using ELISA.
Results: A total of 98 subjects (92.5%) completed the study. Immune response of LBW subjects
were positive in 89.7%, newborns were 95.9%. The Relative Risk (RR) were 2.5 CI (0.50 to 12.2)
p=0.2178. Gender was not related to immune response RR 0.6 CI (0.15 to 2.69) p=0.6996. Gestational
age associated with immune response RR 8 CI (1.05 to 63.9) p=0.0399. The first 6 months weight
was not related to immune response RR 3.6 CI (0.73 to 17.7) p=0.1178. Logistic regression analysis
showed LBW was not correlated with the immune response OR 1 CI (0.16 to 7.17) p=0.929. Gestational
age correlated with immune response OR 9 CI (1.05 to 79.3) p=0.044 and the first 6 months of
weight was not correlated with immune response OR 3.7 CI (0.65 to 21.1) p=0.138.
Conclusion: Immune response against HBV after vaccination was similar between LBW and NBW.
Immune response was correlated with gestational age.
Keywords: Hepatitis B vaccine, immune response, LBW and preterm.
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INTISARI
Pendahuluan: Infeksi Virus Hepatitis B (HBV) adalah salah satu peyebab utama mobiditas dan
mortalitas di duna. Lebih dari 2 miliar orang terinfeksi oleh HBV dan 378 juta adalah karier. Angka
mortalitas berkisar 1-2 juta dan lebih dari 4 juta kasus akut terjadi setiap tahunnya. Prevalensi
infeksi HBV di Indonesia adalah 3-20%. Penularan vertikal dan horizontal pada bayi baru lahir dan
anak-anak terjadi 25-45%. Hampir 25-50% anak-anak terinfeksi HBV sebelum usia 5 tahun.
Pendekatan paling efektif untuk mengurangi infeksi HBV adalah dengan melakukan vaksinasi masal
pada bayi baru lahir dan anak-anak.
Tujuan: Penelitian ini bertujuan untuk mengetahui respon imun terhadap HBV pasca vaksinasi diantara
bayi berat lahir rendah (BBLR) dan bayi lahir kurang bulan. Serta untuk mengetahui faktor yang
berhubungan dengan respon imun seperti jenis kelamin dan pertumbuhan berat badan pada enam
bulan pertama.
Metode : Selama bulan Mei-Juli 2012 telah dilakukan penelitian pada 106 anak usia 13-15 bulan
yang telah divaksinasi HBV empat kali pada usia 0, 2, 3, dan 4 bulan. Serum diambil dan dilakukan
pengukuran titer anti-HBs antibody dengan metode ELISA.
Hasil : Sebanyak 98 subyek (92,5%) menyelesaikan studi. Respon imun BBLR (89,7%) bersama-sama
dengan NBW (95,9%) RR 2,5 CI (0,50 12,2) p = 0,2178. Jenis kelamin tidak berhubungan dengan
respon imun RR 0,6 CI (0,15 to 2,69) p=0,6996. Usia kehamilan berhubungan dengan respon imun
RR 8 CI (1,05 to 63,9) p=0,0399. Berat bayi enam bulan pertama tidak berhubungan dengan respon
imun RR 3,6 CI (0,73 - 17,7) p=0.1178. Analisis regresi logistic menunjukkan bahwa BBLR tidak
berhubungan dengan respon imun OR 1 CI (0,16 - 7,17) p=0,929. Usia kehamilan berhubungan
dengan respon imun OR 9 CI (1,05 - 79,3) p=0,044 ; dan berat bayi pada enam bulan pertama tidak
berhubungan dengan respon imun OR 3,7 CI (0,65 - 21,1) p=0.138.
Simpulan: respon imun vaksin HBV setara antara BBLR dan bayi berat lahir cukup . Respon imun
berhubungan dengan usia kehamilan.
Kata kunci: Vaksin HBV, respon imun, BBLR dan bayi lahir kurang bulan
INTRODUCTION
Hepatitis B Virus (HBV) infection was the
main cause of morbidity and mortality. The
transmissions of HBV have been become public
health problem in the world. The vertical
transmission from woman to infant was
occurred at 24-45%, increasing the incidence of
new infection of HBV in children.
The frequency of horizontal transmission
was 79%. This was occurred amongst children,
adolescent, adult. It was documented that 25-
50% cases were new HBV infection involving
children before their five year old. This condition
become significant since the younger children
get infection, the more probable to become
chronic carrier1,2.
It was proposed that HBV vaccination
decreases the morbidity and mortality at two third
in 2015. American Academy of Pediatrics (AAP)
recommended the HBV vaccination for the new
born and premature babies or Low Birth Weight
> 000gr. The vaccination schedule is similar with
the normal infant without respect to the status
of HBs Ag of the mother3.
The incidence of LBW and premature babies
has been increasing in the last 15 years. The
newest advance of the caring for LBW and
premature is important to be followed in order
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to substantially increasing the survival3. The
most effective approach to decrease the HBV
infection and breaking the chain of transmission
in their early life is by primary prevention
through mass vaccination for the new born and
children.
A national wide HBV vaccination programs
was performed in Indonesia in 1997. One series
of HBV vaccination able to gain optimal immune
response at 95% in infant, children, adolescent
and healthy adult4. Studies on immune response
against HBV after vaccination was not conclusive
reported that immune response against HBV
was found lower in premature than the aterm
infant5.
Other studies6,7 reported that, the
premature and LBW infants have immune
response that is comparable to the normal
infants after hepatitis B vaccination with three
doses in the different population.
Considering this inconclusive data, study to
measure the immune response in LBW and
normal infant and other factors that is influence
the immune response is interesting.
MATERIALS AND METHODS
Subjects:
This was retrospective cohort study. Two
parallel groups were observed in August to
October 2013. Sampling was performed by
cluster sampling in three area of Public Health
Center with high incidence of LBW in Magelang
District.This study had been approved by
Research Ethic Committee of Faculty of Medicine,
Universitas Gadjah Mada (MHREC). The subjects
were consisted of 53 LBW infants and 53 normal
birth weight (NBW) infants who have complete
4 series of the HBV vaccination at 0, 2, 3, and 4
months of their ages. The mothers, who their
children was selected as subject, were invited
to Public Health Center and Integrated Service
Post. Informed consents were obtained from the
mothers. Data were collected from medical
records and child health cards.
Anti-HBs antibody titer measurement
Children were donate 1.5-2 ìl of blood. Titer
of anti-HBs antibody was measured by using
ELISA method. The anti-HBs antibody titer was
categorized as negative if their anti-HBs titer is
less than 10 IU/L and positive if more than 10
IU/L.
Statistical analysis
the correlation between two variable were
analyzed using fisher’s exact test and
multivariable analysis by using logistic
regression, with significance level p<0.05, and
confidence level at 95%.
RESULTS AND DISCUSSIONS
The study was performed at Salaman 1,
Salaman 2 and Borobudur Primary Health Care.
Table 1 summarized the variables which were
studied among LBW and normal children.
Table1. The characteristic of subjects involved in
the study
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Table 2. Relationship between birth weight, sex, gestational age and Weight the First
6 month weight and anti-HBs titers
Note: *: p=<0,05
Table 2 showed the association analysis
between birth weight, sex, gestational age and
the first 6 month weight with anti-HBs titers.
There was significant association between
gestational ages and immune response (p<0.05).
Table 3 showed the significant positive
correlation between the gestational age with the
immune response p=0.044, OR=9.1 and 95%CI
(1.05-79.3).
It was recommended by American Academy
of Pediatrics that vaccination of HBV in the
newborn particularly the premature > 2000 gram
and LBW (with good clinical condition) with same
vaccination schedule to the normal infant
appropriate to the chronological age or
vaccination schedule without respect to the
status of HBsAg of the woman3,10.
Table 3 showed the logistic regression
indicated that LBW infant had immune response
89.8% comparable with the normal birth weight
95.9% immune response. It was statistically had
no difference, OR=1, 95% CI (0.16-7.18), p value=
0.929.
It was reported that immune response
against HBV between LBW infant <2500 gram
normal birth weight infant e”2500 gram was
comparable. The HBV vaccine showed effective
and safe to prevent the newborn, children, and
adult from the transmission of HBV7,6.
HBV vaccination with three dosages resulted
in 90-99% newborn, children, adolescent and
adult develop optimal immune response. It
showed by the titer of anti-HBs >10 IU/L, and
only 5-10% of the infant, health children, and
adult who were vaccinated did not form optimal
immune response11.
Gestational age was one of parameter that
might be used for assess immune response in
premature infant3. Table 2 described that
gestational age <37 week contributed to 9 times
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5. Soares M, Mussi-pinhata MM, Moysés S,
Fumiko C, Yoshida T, Barbosa C, Souza S De.
Immunogenicity of Hepatitis B vaccine in
preterm and full term infants vaccinated
within the first week of life, 2002;20:1557-
62.
6. Belloni C, Chirico G, Pistorio A, Orsolini P,
Tinelli C, Rondini G. HBV vaccine/ :
Immunogenicity of Hepatitis B Vaccine in
Term and Pretrm Infants. Acta pediatrica,
1998(March):336-8.
7. Lumblganon P, Kowsuwan P, Lumbiganon P,
Taksaphan S, Panamonta M, Assateerawatts
A. Comparisonof ImmunogenicityofHepatitis
B Vaccine Between Low and Normal Birth
Weight Infants, 1992;61-3.
8. IDAI.Pedoman Imunisasi di Indonesia. 4th ed.
Rahun, G. Suyitno, H. Hadinegoro, S. Karta-
sasmita, C. Ismoedijanto S, editor. Ikatan
Dokter Anak Indonesia, 2011.
9. Depkes RI. Riset Kesehatan Dasar 2007, 2007.
10. Gad A, Shah S.Special Immunization Conside-
rations of the Preterm Infant, 2007
(December): 385-91.
11. Eldesoky A, Mosaad Y, Zakria Y, Hamdy S.
Protective immunity after hepatitis B
vaccination. Arab Journal of Gastroentero-
logy. Arab Journal of Gastroenterology,
2009;10(2):68-71. Available from: URL: http:/
/dx.doi.org/10.1016/j.ajg. 2009.05.002.
Table 3. Multivariable analysis for variables associated with Anti-HBs titers
Note: * p = <0,05
greater risk to have negative immune response
compared to the gestational age >37 week. OR=
9.1 and 95 CI 1.05-79.3; p value=0.044.
Previous study reported that premature
infant had correlation to the decreasing of
immunogenicity after the provision of 3 dosage
of HBV vaccine and lower titer anti-HBs antibody
compared to the aterm infant10,5.
CONCLUSION
The immune response against HBV of HBV
vaccinated LBW infant was comparable to the
normal infant. Immune response was correlated
with gestational age.
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